C L Bennett|D Deneffe - JoVE Visualize

Showing results (51-60 of 166) with videos related to

Pageof 17

Sort By:

Clinical and Experimental Pharmacology & Physiology|November 1, 1994

Frequencies of variants of candidate genes in different age groups of hypertensivesR Y Zee, C L Bennett, A P Schrader, et al.

JAMA|October 27, 1999

Evaluation of conflict of interest in economic analyses of new drugs used in oncologyM Friedberg, B Saffran, T J Stinson, et al.

The Review of Scientific Instruments|September 8, 2011

Note: Vector reflectometry in a beam waveguideJ R Eimer, C L Bennett, D T Chuss, et al.

The Astrophysical Journal|April 8, 2020

Beyond Optical Depth: Future Determination of Ionization History from the Cosmic Microwave BackgroundD J Watts, G E Addison, C L Bennett, et al.

Journal of Acquired Immune Deficiency Syndromes|January 1, 1991

Intensity of in-hospital care for persons with AIDSC L Bennett, L Graf, N Hunter-Young, et al.

Cancer Investigation|December 11, 1999

Cost analysis of second-line therapies for platinum-refractory ovarian cancer: reimbursement dilemmas for Medicare patientsT J Stinson, E Calhoun, T Yang, et al.

The Western Journal of Medicine|July 1, 1992

Health care use by human immunodeficiency virus-infected students at a California student health serviceC L Bennett, H Chang, D Shlian, et al.

Journal of Acquired Immune Deficiency Syndromes|January 1, 1992

Medical care costs of intravenous drug users with AIDS in BrooklynC L Bennett, A Pascal, M Cvitanic, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999

Use of hematopoietic colony-stimulating factors: comparison of the 1994 and 1997 American Society of Clinical Oncology surveys regarding ASCO clinical practice guidelines. Health Services Research Committee of the American Society of Clinical OncologyC L Bennett, J A Weeks, M R Somerfield, et al.

Cancer Research|April 1, 1987

Phase I clinical and pharmacological study of 72-hour continuous infusion of etoposide in patients with advanced cancerC L Bennett, J A Sinkule, R L Schilsky, et al.

Pageof 17

Showing results (51-60 of 166) with videos related to

Sort By:

Pageof 17

Clinical and Experimental Pharmacology & Physiology|November 1, 1994

Frequencies of variants of candidate genes in different age groups of hypertensivesR Y Zee, C L Bennett, A P Schrader, et al.

JAMA|October 27, 1999

Evaluation of conflict of interest in economic analyses of new drugs used in oncologyM Friedberg, B Saffran, T J Stinson, et al.

The Review of Scientific Instruments|September 8, 2011

Note: Vector reflectometry in a beam waveguideJ R Eimer, C L Bennett, D T Chuss, et al.

The Astrophysical Journal|April 8, 2020

Beyond Optical Depth: Future Determination of Ionization History from the Cosmic Microwave BackgroundD J Watts, G E Addison, C L Bennett, et al.

Journal of Acquired Immune Deficiency Syndromes|January 1, 1991

Intensity of in-hospital care for persons with AIDSC L Bennett, L Graf, N Hunter-Young, et al.

Cancer Investigation|December 11, 1999

Cost analysis of second-line therapies for platinum-refractory ovarian cancer: reimbursement dilemmas for Medicare patientsT J Stinson, E Calhoun, T Yang, et al.

The Western Journal of Medicine|July 1, 1992

Health care use by human immunodeficiency virus-infected students at a California student health serviceC L Bennett, H Chang, D Shlian, et al.

Journal of Acquired Immune Deficiency Syndromes|January 1, 1992

Medical care costs of intravenous drug users with AIDS in BrooklynC L Bennett, A Pascal, M Cvitanic, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999

Use of hematopoietic colony-stimulating factors: comparison of the 1994 and 1997 American Society of Clinical Oncology surveys regarding ASCO clinical practice guidelines. Health Services Research Committee of the American Society of Clinical OncologyC L Bennett, J A Weeks, M R Somerfield, et al.

Cancer Research|April 1, 1987

Phase I clinical and pharmacological study of 72-hour continuous infusion of etoposide in patients with advanced cancerC L Bennett, J A Sinkule, R L Schilsky, et al.

Pageof 17